OtherBRAIN
Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements
L.S. Hu, L.C. Baxter, K.A. Smith, B.G. Feuerstein, J.P. Karis, J.M. Eschbacher, S.W. Coons, P. Nakaji, R.F. Yeh, J. Debbins and J.E. Heiserman
American Journal of Neuroradiology December 2008, DOI: https://doi.org/10.3174/ajnr.A1377
L.S. Hu
L.C. Baxter
K.A. Smith
B.G. Feuerstein
J.P. Karis
J.M. Eschbacher
S.W. Coons
P. Nakaji
R.F. Yeh
J. Debbins
This is a PDF-only article. The first page of the PDF of this article appears above.
Advertisement
Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements
L.S. Hu, L.C. Baxter, K.A. Smith, B.G. Feuerstein, J.P. Karis, J.M. Eschbacher, S.W. Coons, P. Nakaji, R.F. Yeh, J. Debbins, J.E. Heiserman
American Journal of Neuroradiology Dec 2008, DOI: 10.3174/ajnr.A1377
Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements
L.S. Hu, L.C. Baxter, K.A. Smith, B.G. Feuerstein, J.P. Karis, J.M. Eschbacher, S.W. Coons, P. Nakaji, R.F. Yeh, J. Debbins, J.E. Heiserman
American Journal of Neuroradiology Dec 2008, DOI: 10.3174/ajnr.A1377
Jump to section
Related Articles
Cited By...
- Arterial Spin-Labeling and DSC Perfusion Metrics Improve Agreement in Neuroradiologists Clinical Interpretations of Posttreatment High-Grade Glioma Surveillance MR Imaging--An Institutional Experience
- Radiotherapy delays malignant transformation and prolongs survival in patients with IDH-mutant gliomas
- Volumetric Measurement of Relative CBV Using T1-Perfusion-Weighted MRI with High Temporal Resolution Compared with Traditional T2*-Perfusion-Weighted MRI in Postoperative Patients with High-Grade Gliomas
- Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies
- Effects of Susceptibility Artifacts on Perfusion MRI in Patients with Primary Brain Tumor: A Comparison of Arterial Spin-Labeling versus DSC
- Response Assessment in Neuro-Oncology Criteria for Gliomas: Practical Approach Using Conventional and Advanced Techniques
- Perfusion MRI-Based Fractional Tumor Burden Differentiates between Tumor and Treatment Effect in Recurrent Glioblastomas and Informs Clinical Decision-Making
- Accurate Patient-Specific Machine Learning Models of Glioblastoma Invasion Using Transfer Learning
- Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy
- Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project
- Optimization of DSC MRI Echo Times for CBV Measurements Using Error Analysis in a Pilot Study of High-Grade Gliomas
- Classification of High-Grade Glioma into Tumor and Nontumor Components Using Support Vector Machine
- Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma
- Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma
- ASFNR Recommendations for Clinical Performance of MR Dynamic Susceptibility Contrast Perfusion Imaging of the Brain
- Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence
- Dynamic Contrast-Enhanced Perfusion Processing for Neuroradiologists: Model-Dependent Analysis May Not Be Necessary for Determining Recurrent High-Grade Glioma versus Treatment Effect
- Histogram Analysis of Intravoxel Incoherent Motion for Differentiating Recurrent Tumor from Treatment Effect in Patients with Glioblastoma: Initial Clinical Experience
- Prediction of Pseudoprogression in Patients with Glioblastomas Using the Initial and Final Area Under the Curves Ratio Derived from Dynamic Contrast-Enhanced T1-Weighted Perfusion MR Imaging
- Accurate Differentiation of Recurrent Gliomas from Radiation Injury by Kinetic Analysis of {alpha}-11C-Methyl-L-Tryptophan PET
- The Role of Preload and Leakage Correction in Gadolinium-Based Cerebral Blood Volume Estimation Determined by Comparison with MION as a Criterion Standard
- Does MR Perfusion Imaging Impact Management Decisions for Patients with Brain Tumors? A Prospective Study
- Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma
- Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours
- Prospective Analysis of Parametric Response Map-Derived MRI Biomarkers: Identification of Early and Distinct Glioma Response Patterns Not Predicted by Standard Radiographic Assessment
- O-(2-18F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade Glioma
- Permeability Estimates in Histopathology-Proved Treatment-Induced Necrosis Using Perfusion CT: Can These Add to Other Perfusion Parameters in Differentiating from Recurrent/Progressive Tumors?
- Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation Status
- Optimized Preload Leakage-Correction Methods to Improve the Diagnostic Accuracy of Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging in Posttreatment Gliomas
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
- Ramon F. Barajas, Jamie S. Chang, Mark R. Segal, Andrew T. Parsa, Michael W. McDermott, Mitchel S. Berger, Soonmee ChaRadiology 2009 253 2
- Frederic G Dhermain, Peter Hau, Heinrich Lanfermann, Andreas H Jacobs, Martin J van den BentThe Lancet Neurology 2010 9 9
- Dieta Brandsma, Martin J van den BentCurrent Opinion in Neurology 2009 22 6
- Karl-Josef Langen, Norbert Galldiks, Elke Hattingen, Nadim Jon ShahNature Reviews Neurology 2017 13 5
- Luke Macyszyn, Hamed Akbari, Jared M. Pisapia, Xiao Da, Mark Attiah, Vadim Pigrish, Yingtao Bi, Sharmistha Pal, Ramana V. Davuluri, Laura Roccograndi, Nadia Dahmane, Maria Martinez-Lage, George Biros, Ronald L. Wolf, Michel Bilello, Donald M. O'Rourke, Christos DavatzikosNeuro-Oncology 2016 18 3
- Wojciech Szopa, Thomas A. Burley, Gabriela Kramer-Marek, Wojciech KasperaBioMed Research International 2017 2017
- Stefanie C. Thust, Martin J. van den Bent, Marion SmitsJournal of Magnetic Resonance Imaging 2018 48 3
- Ritu Shah, Surjith Vattoth, Rojymon Jacob, Fathima Fijula Palot Manzil, Janis P. O’Malley, Peyman Borghei, Bhavik N. Patel, Joel K. CuréRadioGraphics 2012 32 5
- Michael A. Vogelbaum, Sarah Jost, Manish K. Aghi, Amy B. Heimberger, John H. Sampson, Patrick Y. Wen, David R. Macdonald, Martin J. Van den Bent, Susan M. ChangNeurosurgery 2012 70 1
- Praneil Patel, Hediyeh Baradaran, Diana Delgado, Gulce Askin, Paul Christos, Apostolos John Tsiouris, Ajay GuptaNeuro-Oncology 2017 19 1
More in this TOC Section
Similar Articles
Advertisement